Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Clinical trial NCT02184195 · COMPLETED

Trial details

NCT number: NCT02184195
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Germline BRCA1/2 Mutations and Metastatic Adenocarcinoma of the Pancreas

Start date: 2014-12-16
Primary completion: 2019-01-15
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.